Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ferrant

Showing results (121-130 of 234) with videos related to

Pageof 24
Sort By:
Leukemia & Lymphoma|May 1, 1996
Limited activity of mini-dose interferon alpha-2a in the treatment of myelodysplastic syndromeM Maerevoet, E Van Den Neste, A Delannoy, et al.
Cancer Genetics and Cytogenetics|July 21, 2001
Trisomy 16 as the sole anomaly in hematological malignancies. Three new cases and a short reviewB Guillaume, G Ameye, J Dierlamm, et al.
Archives of Disease in Childhood|October 1, 1991
Bone marrow transplantation in sickle cell anaemiaC Vermylen, G Cornu, M Philippe, et al.
Acta Gastro-Enterologica Belgica|March 1, 1991
Scintigraphy with Indium-labelled leukocytes in acute pancreatitisB De Coninck, P Meert, G Hanique, et al.
Annals of Hematology|October 24, 2007
Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOPA Bosly, D Bron, A Van Hoof, et al.
European Journal of Haematology|September 1, 1990
High-dose cytosine arabinoside and amsacrine or mitoxantrone in relapsed and refractory acute myeloid leukaemia: a prospective randomized studyP Martiat, J M Ghilain, A Ferrant, et al.
British Journal of Haematology|July 1, 1990
Detection of residual BCR/ABL transcripts in chronic myeloid leukaemia patients in complete remission using the polymerase chain reaction and nested primersP Martiat, D Maisin, M Philippe, et al.
British Journal of Haematology|September 30, 1998
PRAME, a gene encoding an antigen recognized on a human melanoma by cytolytic T cells, is expressed in acute leukaemia cellsN van Baren, H Chambost, A Ferrant, et al.
International Journal of Antimicrobial Agents|August 11, 2007
Bacteraemia in febrile neutropenic cancer patientsJ Klastersky, L Ameye, J Maertens, et al.
Leukemia|February 19, 2010
KANK1, a candidate tumor suppressor gene, is fused to PDGFRB in an imatinib-responsive myeloid neoplasm with severe thrombocythemiaS Medves, F P Duhoux, A Ferrant, et al.
Pageof 24

Showing results (121-130 of 234) with videos related to

Sort By:
Pageof 24
Leukemia & Lymphoma|May 1, 1996
Limited activity of mini-dose interferon alpha-2a in the treatment of myelodysplastic syndromeM Maerevoet, E Van Den Neste, A Delannoy, et al.
Cancer Genetics and Cytogenetics|July 21, 2001
Trisomy 16 as the sole anomaly in hematological malignancies. Three new cases and a short reviewB Guillaume, G Ameye, J Dierlamm, et al.
Archives of Disease in Childhood|October 1, 1991
Bone marrow transplantation in sickle cell anaemiaC Vermylen, G Cornu, M Philippe, et al.
Acta Gastro-Enterologica Belgica|March 1, 1991
Scintigraphy with Indium-labelled leukocytes in acute pancreatitisB De Coninck, P Meert, G Hanique, et al.
Annals of Hematology|October 24, 2007
Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOPA Bosly, D Bron, A Van Hoof, et al.
European Journal of Haematology|September 1, 1990
High-dose cytosine arabinoside and amsacrine or mitoxantrone in relapsed and refractory acute myeloid leukaemia: a prospective randomized studyP Martiat, J M Ghilain, A Ferrant, et al.
British Journal of Haematology|July 1, 1990
Detection of residual BCR/ABL transcripts in chronic myeloid leukaemia patients in complete remission using the polymerase chain reaction and nested primersP Martiat, D Maisin, M Philippe, et al.
British Journal of Haematology|September 30, 1998
PRAME, a gene encoding an antigen recognized on a human melanoma by cytolytic T cells, is expressed in acute leukaemia cellsN van Baren, H Chambost, A Ferrant, et al.
International Journal of Antimicrobial Agents|August 11, 2007
Bacteraemia in febrile neutropenic cancer patientsJ Klastersky, L Ameye, J Maertens, et al.
Leukemia|February 19, 2010
KANK1, a candidate tumor suppressor gene, is fused to PDGFRB in an imatinib-responsive myeloid neoplasm with severe thrombocythemiaS Medves, F P Duhoux, A Ferrant, et al.
Pageof 24